NVDA — 2025

NVIDIA CORP

CIK 1045810

Fact	Value	Filing Year	Description
Entity Common Stock, Shares Outstanding	24,400,000,000	2025	Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Entity Public Float	2,700,000,000,000	2025	The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.
Current Federal Tax Expense (Benefit)	1,703,000,000	2025	Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.
Deferred Income Tax Expense (Benefit)	-2,164,000,000	2025	Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Lessee, Operating Lease, Liability, to be Paid, Year One	354,000,000	2025	Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount	878,000,000	2025	The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.
Other Noncash Income (Expense)	7,000,000	2025	Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value	24.89	2025	The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.
Net Cash Provided by (Used in) Financing Activities	-11,617,000,000	2025	Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Retained Earnings (Accumulated Deficit)	29,817,000,000	2025	The cumulative amount of the reporting entity's undistributed earnings or deficit.
Finite-Lived Intangible Asset, Expected Amortization, Year Two	236,000,000	2025	Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Interest Paid, Excluding Capitalized Interest, Operating Activities	254,000,000	2025	Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Preferred Stock, Par or Stated Value Per Share	0.001	2025	Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
Deferred Tax Liabilities, Gross	891,000,000	2025	Amount of deferred tax liability attributable to taxable temporary differences.
Liabilities	22,750,000,000	2025	Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
Prepaid Expense and Other Assets, Current	3,080,000,000	2025	Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	89,000,000	2025	The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
Other Comprehensive Income (Loss), Net of Tax	-32,000,000	2025	Amount after tax and reclassification adjustments of other comprehensive income (loss).
Payments for Repurchase of Common Stock	10,039,000,000	2025	The cash outflow to reacquire common stock during the period.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount	279,000,000	2025	Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	9,000,000	2025	The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period	173,000,000	2025	The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.
Revenues	26,974,000,000	2025	Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Research and Development Expense	7,339,000,000	2025	The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.
Operating Lease, Liability, Current	228,000,000	2025	Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Preferred Stock, Shares Authorized	20,000,000	2025	The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Common Stock, Shares, Outstanding	24,643,000,000	2025	Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Goodwill, Impairment Loss	0	2025	Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Selling, General and Administrative Expense	2,440,000,000	2025	The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.
Purchase Obligation, to be Paid, Year Five	422,000,000	2025	Amount of purchase arrangement to be paid in fifth fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Inventory, Raw Materials, Net of Reserves	1,719,000,000	2025	Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.
Inventory, Work in Process, Net of Reserves	1,505,000,000	2025	Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.
Earnings Per Share, Basic	0.18	2025	The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Purchase Obligation, to be Paid, Year Two	3,666,000,000	2025	Amount of purchase arrangement to be paid in second fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Liabilities, Current	10,631,000,000	2025	Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Operating Lease, Weighted Average Discount Rate, Percent	0.0376	2025	Weighted average discount rate for operating lease calculated at point in time.
Capital Expenditures Incurred but Not yet Paid	374,000,000	2025	Future cash outflow to pay for purchases of fixed assets that have occurred.
Long-term Debt, Current Maturities	1,250,000,000	2025	Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
Finite-Lived Intangible Asset, Expected Amortization, Year One	354,000,000	2025	Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Proceeds from Stock Plans	355,000,000	2025	The cash inflow associated with the amount received from the stock plan during the period.
Inventory, Net	5,282,000,000	2025	Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
Deferred State and Local Income Tax Expense (Benefit)	0	2025	Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.
Goodwill, Acquired During Period	758,000,000	2025	Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.
Finite-Lived Intangible Asset, Expected Amortization, Year Four	31,000,000	2025	Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Deferred Tax Assets, Other	179,000,000	2025	Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	1,399,000,000	2025	Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Income Taxes Paid, Net	1,404,000,000	2025	The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.
Accounts Payable, Current	2,699,000,000	2025	Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Lessee, Operating Lease, Liability, to be Paid, after Year Five	537,000,000	2025	Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Increase (Decrease) in Accounts Receivable	-822,000,000	2025	The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	358,000,000	2025	Amount of increase in right-of-use asset obtained in exchange for operating lease liability.
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost	106,000,000	2025	Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax	49,000,000	2025	Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.
Other Assets, Noncurrent	4,500,000,000	2025	Amount of noncurrent assets classified as other.
Stockholders' Equity Attributable to Parent	26,612,000,000	2025	Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
Accumulated Other Comprehensive Income (Loss), Net of Tax	27,000,000	2025	Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.
Operating Expenses	11,132,000,000	2025	Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	24.59	2025	Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.
Contract with Customer, Liability, Revenue Recognized	338,000,000	2025	Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.
Increase (Decrease) in Inventories	2,554,000,000	2025	The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.
Net Income (Loss) Attributable to Parent	4,368,000,000	2025	The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Deferred Tax Assets, Valuation Allowance	1,552,000,000	2025	Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Net Cash Provided by (Used in) Investing Activities	7,375,000,000	2025	Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Operating Income (Loss)	4,224,000,000	2025	The net result for the period of deducting operating expenses from operating revenues.
Depreciation	844,000,000	2025	The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Deferred Foreign Income Tax Expense (Benefit)	1,000,000	2025	Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.
Deferred Tax Assets, Net	5,617,000,000	2025	Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.
Common Stock, Value, Issued	25,000,000	2025	Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Deferred Tax Assets, Operating Loss Carryforwards	439,000,000	2025	Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Purchase Obligation, to be Paid, after Year Five	218,000,000	2025	Amount of purchase arrangement to be paid after fifth fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Finite-Lived Intangible Asset, Expected Amortization, Year Five	10,000,000	2025	Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Purchase Obligation, to be Paid, Year Four	2,054,000,000	2025	Amount of purchase arrangement to be paid in fourth fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Unrecognized Tax Benefits that Would Impact Effective Tax Rate	2,000,000,000	2025	The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.
Payments for (Proceeds from) Other Investing Activities	0	2025	Amount of cash (inflow) outflow from investing activities classified as other.
Share-based Payment Arrangement, Expense	2,710,000,000	2025	Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Common Stock, Shares Authorized	80,000,000,000	2025	The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Inventory, Finished Goods, Net of Reserves	2,058,000,000	2025	Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.
Other Assets, Miscellaneous, Noncurrent	357,000,000	2025	Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer.
Current State and Local Tax Expense (Benefit)	46,000,000	2025	Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.
Deferred Federal Income Tax Expense (Benefit)	-2,165,000,000	2025	Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.
Weighted Average Number of Shares Outstanding, Basic	24,870,000,000	2025	Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Income Tax Expense (Benefit)	-187,000,000	2025	Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Property, Plant and Equipment, Gross	7,423,000,000	2025	Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense	33,000,000	2025	Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.
Finite-Lived Intangible Assets, Accumulated Amortization	1,979,000,000	2025	Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	1,990,000,000	2025	Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	4,336,000,000	2025	Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Share-based Payment Arrangement, Noncash Expense	2,709,000,000	2025	Amount of noncash expense for share-based payment arrangement.
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value	87.99	2025	The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
Deferred Tax Assets, Net of Valuation Allowance	6,508,000,000	2025	Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
APIC, Share-based Payment Arrangement, Increase for Cost Recognition	2,710,000,000	2025	Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount	-83,000,000	2025	Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).
Investment Income, Interest	267,000,000	2025	Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.
Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions	15,000,000	2025	Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.
Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations	20,000,000	2025	Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.
Lessee, Operating Lease, Liability, to be Paid, Year Five	226,000,000	2025	Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities	9,000,000	2025	Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount	50,000,000	2025	Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	4,181,000,000	2025	Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount	-309,000,000	2025	Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.
Operating Lease, Liability, Noncurrent	1,119,000,000	2025	Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Payment, Tax Withholding, Share-based Payment Arrangement	1,475,000,000	2025	Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.
Amortization of Intangible Assets	699,000,000	2025	The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Finite-Lived Intangible Asset, Expected Amortization, after Year Five	92,000,000	2025	Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	3,509,000,000	2025	Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.
Contract with Customer, Liability, Current	764,000,000	2025	Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
Long-term Debt	9,709,000,000	2025	Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions	268,000,000	2025	Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.
Accrued Income Taxes, Noncurrent	1,361,000,000	2025	Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.
Finite-Lived Intangible Assets, Gross	3,091,000,000	2025	Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net	41,000,000	2025	Amount of unamortized debt discount (premium) and debt issuance costs.
Increase (Decrease) in Accounts Payable	-551,000,000	2025	The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.
Common Stock, Par or Stated Value Per Share	0.001	2025	Face amount or stated value per share of common stock.
Revenue, Remaining Performance Obligation, Amount	1,700,000,000	2025	Amount of transaction price allocated to performance obligation that has not been recognized as revenue.
Lessee, Operating Lease, Liability, to be Paid, Year Two	331,000,000	2025	Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions	1,000,000	2025	Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.
Contract with Customer, Liability, Noncurrent	573,000,000	2025	Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.
Earnings Per Share, Diluted	0.17	2025	The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Other Accrued Liabilities, Current	199,000,000	2025	Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.
Other Sundry Liabilities, Noncurrent	65,000,000	2025	Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are expected to be paid after one year (or the normal operating cycle, if longer), from the balance sheet date.
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	-2,000,000	2025	Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.
Assets, Current	44,345,000,000	2025	Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Property, Plant and Equipment, Net	3,914,000,000	2025	Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
Cash and Cash Equivalents, at Carrying Value	7,280,000,000	2025	Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Effective Income Tax Rate Reconciliation, Percent	-0.045	2025	Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Finite-Lived Intangible Assets, Net	1,112,000,000	2025	Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
Accrued Liabilities, Current	6,682,000,000	2025	Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Operating Lease, Liability	1,807,000,000	2025	Present value of lessee's discounted obligation for lease payments from operating lease.
Lessee, Operating Lease, Liability, to be Paid, Year Three	337,000,000	2025	Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Preferred Stock, Shares Issued	0	2025	Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.
Purchase Obligation, to be Paid, Year One	35,727,000,000	2025	Amount of purchase arrangement to be paid in next fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued	140,000,000	2025	Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.
Other Nonoperating Income (Expense)	-48,000,000	2025	Amount of income (expense) related to nonoperating activities, classified as other.
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	0.21	2025	Percentage of domestic federal statutory tax rate applicable to pretax income (loss).
Number of Reportable Segments	2	2025	Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.
Operating Lease, Right-of-Use Asset	1,346,000,000	2025	Amount of lessee's right to use underlying asset under operating lease.
Weighted Average Number of Shares Outstanding, Diluted	25,070,000,000	2025	The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Current Foreign Tax Expense (Benefit)	228,000,000	2025	Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.
Deferred Income Tax Assets, Net	6,081,000,000	2025	Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.
Deferred Income Tax Liabilities, Net	462,000,000	2025	Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Lessee, Operating Lease, Liability, to be Paid, Year Four	301,000,000	2025	Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Unrecognized Tax Benefits	1,013,000,000	2025	Amount of unrecognized tax benefits.
Finite-Lived Intangible Asset, Expected Amortization, Year Three	84,000,000	2025	Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Lessee, Operating Lease, Liability, to be Paid	2,086,000,000	2025	Amount of lessee's undiscounted obligation for lease payment for operating lease.
Operating Lease, Cost	193,000,000	2025	Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.
Current Income Tax Expense (Benefit)	1,977,000,000	2025	Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
Purchase Obligation, to be Paid, Year Three	2,992,000,000	2025	Amount of purchase arrangement to be paid in third fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Share-based Payment Arrangement, Decrease for Tax Withholding Obligation	1,475,000,000	2025	Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.
Assets	65,728,000,000	2025	Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Increase (Decrease) in Other Noncurrent Liabilities	252,000,000	2025	Amount of increase (decrease) in noncurrent operating liabilities classified as other.
Liabilities and Equity	65,728,000,000	2025	Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Operating Lease, Payments	184,000,000	2025	Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Payments to Acquire Businesses, Net of Cash Acquired	49,000,000	2025	The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.
Employee-related Liabilities, Current	675,000,000	2025	Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Accounts Receivable, after Allowance for Credit Loss, Current	9,999,000,000	2025	Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Goodwill	4,430,000,000	2025	Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Proceeds from (Payments for) Other Financing Activities	-2,000,000	2025	Amount of cash inflow (outflow) from financing activities classified as other.
Net Cash Provided by (Used in) Operating Activities	5,641,000,000	2025	Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Long-term Debt, Excluding Current Maturities	8,459,000,000	2025	Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
Other Liabilities, Noncurrent	2,541,000,000	2025	Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	56,000,000	2025	Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Debt Securities, Available-for-sale, Amortized Cost	25,684,000,000	2025	Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Payments to Acquire Debt Securities, Available-for-sale	11,897,000,000	2025	Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Deferred Tax Assets, Gross	8,060,000,000	2025	Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Stock Repurchased and Retired During Period, Value	10,039,000,000	2025	Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One	16,336,000,000	2025	Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	9,000,000	2025	Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.
Debt Securities, Available-for-sale, Unrealized Loss Position	7,015,000,000	2025	Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.
Deferred Tax Liabilities, Intangible Assets	74,000,000	2025	Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	16,000,000	2025	Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Debt Securities, Available-for-sale	25,724,000,000	2025	Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Taxes Payable, Current	296,000,000	2025	Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax	-31,000,000	2025	Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.
Depreciation, Depletion and Amortization	1,544,000,000	2025	The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Gross Profit	15,356,000,000	2025	Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.
Additional Paid in Capital	13,109,000,000	2025	Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.
Effective Income Tax Rate Reconciliation, Other Adjustments, Percent	0.008	2025	Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.
Income (Loss) from Continuing Operations before Income Taxes, Domestic	3,477,000,000	2025	The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent	-0.074	2025	Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.
Cost of Revenue	11,618,000,000	2025	The aggregate cost of goods produced and sold and services rendered during the reporting period.
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	7,000,000	2025	Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	400,000,000	2025	Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount	11,600,000,000	2025	Amount of cost not yet recognized for nonvested award under share-based payment arrangement.
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent	0.012	2025	Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	16,000,000	2025	Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One	16,329,000,000	2025	Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Defined Contribution Plan, Cost	227,000,000	2025	Amount of cost for defined contribution plan.
Deferred Tax Assets, Tax Credit Carryforwards	936,000,000	2025	Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.
Common Stock, Shares, Issued	24,643,000,000	2025	Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months	5,319,000,000	2025	Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.
Contract with Customer, Liability	572,000,000	2025	Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer	1,696,000,000	2025	Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.
Nonoperating Income (Expense)	-43,000,000	2025	The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Stock Repurchased and Retired During Period, Shares	210,000,000	2025	Number of shares that have been repurchased and retired during the period.
Weighted Average Number Diluted Shares Outstanding Adjustment	200,000,000	2025	The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.
Undistributed Earnings of Foreign Subsidiaries	1,400,000,000	2025	Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.
Cash Equivalents, at Carrying Value	7,020,000,000	2025	Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Standard and Extended Product Warranty Accrual	46,000,000	2025	Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.
	262,000,000	2025
Long-Lived Assets	3,914,000,000	2025	Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent	-0.02	2025	Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	1,500,000,000	2025	The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.
Intangible Assets, Net (Excluding Goodwill)	1,112,000,000	2025	Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.
Tax Credit Carryforward, Valuation Allowance	1,600,000,000	2025	Amount of valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from tax credit carryforwards for which it is more likely than not that a tax benefit will not be realized.
Debt, Current	1,250,000,000	2025	Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.
Inventory Write-down	774,000,000	2025	Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.
Effective Income Tax Rate Reconciliation, Other Adjustments, Amount	33,000,000	2025	Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.
Income (Loss) from Continuing Operations before Income Taxes, Foreign	704,000,000	2025	The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.
Payments to Acquire Productive Assets	1,833,000,000	2025	The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.
Standard and Extended Product Warranty Accrual, Increase for Warranties Issued	145,000,000	2025	Amount of increase in the standard and extended product warranty accrual from warranties issued.
Deferred Tax Liabilities, Undistributed Foreign Earnings	502,000,000	2025	Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences.
Standard and Extended Product Warranty Accrual, Decrease for Payments	109,000,000	2025	Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.
Payments of Dividends	398,000,000	2025	Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number	367,000,000	2025	Number of equity instruments other than options outstanding, including both vested and non-vested instruments.
Increase (Decrease) in Prepaid Expense and Other Assets	1,517,000,000	2025	Amount of increase (decrease) in prepaid expenses, and assets classified as other.
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value	32.1	2025	Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.
Gain (Loss) on Investments	-45,000,000	2025	Amount of realized and unrealized gain (loss) on investment.
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent	0.066	2025	Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale	19,425,000,000	2025	Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent	-30,000,000	2025	Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.
Repayments of Debt	0	2025	The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.
Proceeds from Sale of Debt Securities, Available-for-sale	1,806,000,000	2025	Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Marketable Securities, Current	18,704,000,000	2025	Amount of investment in marketable security, classified as current.
Marketable Securities	18,704,000,000	2025	Amount of investment in marketable security.
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax	-1,000,000	2025	Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.
Commitments and Contingencies	0	2025	Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax	47,000,000	2025	Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.
Deferred Tax Liabilities, Investments	60,000,000	2025	Amount of deferred tax liability attributable to taxable temporary differences from investments (excludes investments in subsidiaries and equity method investments).
Unbilled Contracts Receivable	151,000,000	2025	Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet.
Dividends, Common Stock, Cash	398,000,000	2025	Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.
Finance Lease, Right-of-Use Asset, Accumulated Amortization	400,000,000	2025	Amount of accumulated amortization of right-of-use asset from finance lease.
Common Stock, Dividends, Per Share, Declared	0.016	2025	Aggregate dividends declared during the period for each share of common stock outstanding.
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five	9,348,000,000	2025	Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five	9,395,000,000	2025	Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Equity Securities without Readily Determinable Fair Value, Amount	288,000,000	2025	Amount of investment in equity security without readily determinable fair value.
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities	1,341,000,000	2025	Amount of increase (decrease) in accrued expenses, and obligations classified as other.
	85,000,000	2025
Other Commitment	14,300,000,000	2025	Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.
Purchase Obligation	45,079,000,000	2025	Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.
Preferred Stock, Value, Outstanding	0	2025	Value of all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by shareholders, which is net of related treasury stock. May be all or a portion of the number of preferred shares authorized. These shares represent the ownership interest of the preferred shareholders.
Unrecorded Unconditional Purchase Obligation	7,600,000,000	2025	Amount of the unrecorded obligation to transfer funds in the future for fixed or minimum amounts or quantities of goods or services at fixed or minimum prices (for example, as in take-or-pay contracts or throughput contracts).
Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount	194,000,000	2025	Amount of gain from upward price adjustment on investment in equity security without readily determinable fair value.
Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount	270,000,000	2025	Amount of cumulative gain from upward price adjustment on investment in equity security without readily determinable fair value.
	8,000,000	2025
Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals	1,121,000,000	2025	Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.
Stock Issued During Period, Value, Employee Stock Ownership Plan	355,000,000	2025	Aggregate value of stock issued during the period as a result of employee stock ownership plan (ESOP).
Commercial Paper	0	2025	Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days.
	0.177	2025
	739,000,000	2025
	1,321,000,000	2025
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount	278,000,000	2025	Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.
Income Taxes Receivable, Noncurrent	0	2025	Carrying amount due after one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.
252 facts shown